Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Joseph Guglielmo

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Archives of Internal Medicine|October 13, 2010
A prescription for improved chronic disease management: have community pharmacists function at the top of their training: comment on "Engaging physicians and pharmacists in providing smoking cessation counseling"B Joseph Guglielmo
JAMA Internal Medicine|January 28, 2020
The Cost of Pharmaceutical Company Detailing Visits and Medication SamplesB Joseph Guglielmo
JAMA Internal Medicine|January 2, 2013
The colchicine debacleB Joseph Guglielmo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2020
Metronidazole Neurotoxicity: Suspicions ConfirmedB Joseph Guglielmo
JAMA Internal Medicine|November 30, 2020
The Colchicine Debacle RevisitedB Joseph Guglielmo
The Western Journal of Medicine|March 19, 2002
Patient education for H pylori: who benefits?Katherine Yang, B Joseph Guglielmo
Archives of Internal Medicine|May 25, 2011
Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling"Christine Cheng, B Joseph Guglielmo
The Journal of Antimicrobial Chemotherapy|May 14, 2004
Pharmacokinetics of valaciclovirConan MacDougall, B Joseph Guglielmo
The Annals of Pharmacotherapy|August 2, 2007
Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organismsKatherine Yang, B Joseph Guglielmo
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Incidence and Risk Factors for Vancomycin Nephrotoxicity in Acutely Ill Pediatric PatientsHenock Woldu, B Joseph Guglielmo
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Archives of Internal Medicine|October 13, 2010
A prescription for improved chronic disease management: have community pharmacists function at the top of their training: comment on "Engaging physicians and pharmacists in providing smoking cessation counseling"B Joseph Guglielmo
JAMA Internal Medicine|January 28, 2020
The Cost of Pharmaceutical Company Detailing Visits and Medication SamplesB Joseph Guglielmo
JAMA Internal Medicine|January 2, 2013
The colchicine debacleB Joseph Guglielmo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2020
Metronidazole Neurotoxicity: Suspicions ConfirmedB Joseph Guglielmo
JAMA Internal Medicine|November 30, 2020
The Colchicine Debacle RevisitedB Joseph Guglielmo
The Western Journal of Medicine|March 19, 2002
Patient education for H pylori: who benefits?Katherine Yang, B Joseph Guglielmo
Archives of Internal Medicine|May 25, 2011
Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling"Christine Cheng, B Joseph Guglielmo
The Journal of Antimicrobial Chemotherapy|May 14, 2004
Pharmacokinetics of valaciclovirConan MacDougall, B Joseph Guglielmo
The Annals of Pharmacotherapy|August 2, 2007
Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organismsKatherine Yang, B Joseph Guglielmo
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Incidence and Risk Factors for Vancomycin Nephrotoxicity in Acutely Ill Pediatric PatientsHenock Woldu, B Joseph Guglielmo
Pageof 7